In order to understand the neurobiological underpinnings
of epilepsy in the geriatric population, it is important
to reviewcertain neuropathological events that lead
to neurodegenerative disorders such as Alzheimer’s
disease (AD), and how these events are distinguished
from the neurobiological changes associated with normal
aging that may be related to geriatric epilepsy
or functional decline, such as age-associated memory
impairment (AAMI).